Skip to main content
. 2012 Jan 12;106(3):429–435. doi: 10.1038/bjc.2011.612

Table 1. Human oncogenic viruses and their interactions with the host DNA damage response.

Oncogenic virus Tumors associated with virus infection Oncoproteins involved in DDR References
EBV Burkitt's lymphoma, post-transplant lymphoma, non-Hodgkin's/diffuse large B cell lymphomas, nasopharyngeal carcinoma, gastric carcinoma EBNA2/LP → DDR (Nikitin et al, 2010)
    EBNA1 → ROS → DDR (Gruhne et al, 2009a)
    EBNA3C ⊣ early DDR (Nikitin et al, 2010)
    EBNA3C⊣Chk2,p53 (Choudhuri et al, 2007; Yi et al, 2009)
    EBNA3C⊣ G2/M checkpoint (Gruhne et al, 2009b; Parker et al, 2000)
    LMP1⊣ATM (Gruhne et al, 2009b)
KSHV Kaposi's sarcoma, primary effusion lymphoma v-cyclin → ATM (Koopal et al, 2007)
    LANA → myc → DDR (Liu et al, 2007)
    LANA:p53 (Chen et al, 2010; Friborg et al, 1999)
HPV Cervical cancer, ovarian cancer E6,E7 → repl stress → DDR (Bester et al, 2011)
    E7:pATM (Moody and Laimins, 2009)
    E6⊣p53 (Scheffner et al, 1990)
HBV Hepatocellular carcinoma HBV → ATR (Wang et al, 2008; Zhao et al, 2008a)
    HBx → Ras → DDR (Klein and Schneider, 1997)
    HBx ⊣ p53 (Wang et al, 1994)
HTLV I ATL Tax⊣DNA-PK (Durkin et al, 2008)
    Tax⊣Chk1/Chk2 (Park et al, 2004; Park et al, 2006)
    Tax⊣p53 (Ariumi et al, 2000; Pise-Masison et al, 2000)

Abbreviations: ATL=adult T-cell leukaemia; DDR=DNA damage response; EBV=Epstein–Barr virus; HBV=hepatitis B virus; HPV=human papillomavirus; HTLV-I=human T-lymphotropic virus type I.

HHS Vulnerability Disclosure